ࡱ> 796 5bjbjtt 05,+++++++,-j0+++"++(*p>A)s++0,)8110**L#+P++,1 ~:    Title: Antibiotic Stewardship and Prescribing Policy #PHNE124 Policy: The facility shall work to insure the safe, effective use of antibiotics, and shall actively seek to minimize the inappropriate use of antibiotics through ongoing assessment, education, and leadership activities as part of the facility Infection Prevention and Control Program (IPCP). In accordance with 42 CFR 483.80, the facility will work to employ an Infection Preventionist on or before November 28, 2019. Procedures: The Facility Medical Director, in conjunction with the Infection Preventionist, Director of Nursing, and Consultant Pharmacist shall assume the leadership roles in antibiotic stewardship. The facility shall utilize the services of clinicians with specialized expertise in antibiotic prescribing (e.g.: Infectious Disease Specialists) as deemed clinically necessary. Antibiotic Stewardship activities will be coordinated through the Pharmacy Committee and the Infection Control Committee. Antibiotics Stewardship activities shall include: Regular Review of antibiotic utilization patterns and sensitivity patterns at the committee meetings. Reports from the Laboratory on sensitivity and resistance patterns over time (quarter, year, past years). Review of Antibiotic Utilization over time (quarter, year, past years). Distribution of educational materials to staff on improving safe, effective use of antibiotics as well as materials on prevention of overprescribing on a regular basis in conjunction and coordination with annual Inservice Education to the Nursing Staff and other clinicians with Clinical privileges Reports back to the prescribers on potential mis-prescribing/overprescribing as identified by the Pharmacy and Infection Control Committees, or as identified through monthly Drug Regimen Review. End of Policy. PHNE124  !"1<=>ABDLM i f g {rlcZQK h;pCJhZDh;pCJhZDh!\CJhZDhZDCJ h!\CJh5CJ\hhCJ\hCJaJhZDCJaJhZDhZDCJOJQJaJ hZDCJ h"/4CJ\ hCJ\hZD5CJ\h 05CJ\ h 0CJ h" 5CJ h 5CJ h;p5CJ h 05CJ h5CJ h^.5CJ h 0CJBCDLM f g   | . Y & Fgd!\gd;pgdZD & Fgdgd!\ A B a -/0145 h^.CJhDh>*CJhDh4>*CJhDh >*CJhDh 0>*CJ hGCJ h;pCJ h!\CJ -5gd;p.:pWw/ =!"#$% 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~8XV~_HmH nH sH tH 8`8 Normal_HmH sH tH DA D Default Paragraph FontViV 0 Table Normal :V 44 la (k ( 0No List J^@J ZD0 Normal (Web)dd[$\$OJQJPK!pO[Content_Types].xmlj0Eжr(΢]yl#!MB;.n̨̽\A1&ҫ QWKvUbOX#&1`RT9<l#$>r `С-;c=1g~'}xPiB$IO1Êk9IcLHY<;*v7'aE\h>=^,*8q;^*4?Wq{nԉogAߤ>8f2*<")QHxK |]Zz)ӁMSm@\&>!7;wP3[EBU`1OC5VD Xa?p S4[NS28;Y[꫙,T1|n;+/ʕj\\,E:! t4.T̡ e1 }; [z^pl@ok0e g@GGHPXNT,مde|*YdT\Y䀰+(T7$ow2缂#G֛ʥ?q NK-/M,WgxFV/FQⷶO&ecx\QLW@H!+{[|{!KAi `cm2iU|Y+ ި [[vxrNE3pmR =Y04,!&0+WC܃@oOS2'Sٮ05$ɤ]pm3Ft GɄ-!y"ӉV . `עv,O.%вKasSƭvMz`3{9+e@eՔLy7W_XtlPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-!pO[Content_Types].xmlPK-!֧6 -_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!!Z!theme/theme/theme1.xmlPK-! ѐ'( theme/theme/_rels/themeManager.xml.relsPK]# 5 5 5 8@0(  B S  ?7,7: ʢ{w2'@Ex6nzȇ2H:RQyBZ:@M'^^V.Pe` k*zo ^`OJQJo( 8^8`OJQJo( ^`OJQJo(o  p^ `OJQJo(  @ ^ `OJQJo( x^x`OJQJo( H^H`OJQJo(o ^`OJQJo( ^`OJQJo(l^`lo(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`o(.  ^ `. L ^ `L.xx^x`.HH^H`.L^`L.^`.^`.L^`L.^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.88^8`o(.^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.808^8`0o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.88^8`o(.^`o() L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.^`o(.^`o(.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.^`o(.^`o(.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L. x6nM'^ k*z:RQPeBZ{w (Ů        &                 R        &2B        V        x        $|       /_ UT~CL!{ Ul/_L!{l D^. 0"/4G!\;pWwZD4 " 57@J{5p@UnknownG*Ax Times New Roman5Symbol3 *Cx Arial3Times? *Cx Courier New;WingdingsA$BCambria Math"qhQ'׹XgQ'" " 20223QHP $P 2!xx ,&Title: Adverse Drug Reaction ReportingWilliam C. Hallett Will Hallett0          Oh+'0 (4 X d p |'(Title: Adverse Drug Reaction ReportingWilliam C. Hallett Normal.dotmWill Hallett6Microsoft Macintosh Word@F#@`&%{@`&%{@V-" ՜.+,04 hp  '(Guardian Consulting/Northstar Clinical 2 'Title: Adverse Drug Reaction Reporting Title  !"#$%'()*+,-/0123458Root Entry FiA:1Table L1WordDocument0SummaryInformation(&DocumentSummaryInformation8.CompObj` F Microsoft Word 97-2004 DocumentNB6WWord.Document.8